AN OVERVIEW ON TRICHOMONAS VAGINALIS WITH REFERENCE TO EGYPT | ||||
| Journal of the Egyptian Society of Parasitology | ||||
| Article 5, Volume 51, Issue 2, August 2021, Page 267-280 PDF (819.38 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jesp.2021.192722 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| TAREK ABDEL KADER SALLAM1; LAILA ABDEL-MAWLA MEGAHED1; SHEREEN MOHAMAD IBRAHIM1; TOSSON A. MORSY2 | ||||
| 1Military Medical Academy, Cairo, 11291 | ||||
| 2Department of Parasitology, Faculty of Medicine, Ain Shams University, Cairo 11566 | ||||
| Abstract | ||||
| Trichomoniasis is the most prevalent non-viral sexually transmitted infection worldwide. It is associated with a high prevalence of coinfection with other sexually transmitted diseases and can be identified in 30 to 40% of male sexual partners of infected women. Some possible consequences of trichomonaisis in women include pelvic inflammatory disease, post-hysterectomy cellulitis, and preterm birth; some possible consequences in men include prostatitis, infertility, and prostate cancer. Trichomonas infection in women appears to increase the risk of sexual acquisition of the HIV, preterm birth, and other adverse pregnancy outcomes Clinical manifestations in women range from an asymptomatic carrier state to a severe, acute, inflammatory disease. Signs and symptoms include a purulent, malodorous, thin discharge with associated burning, pruritus, dysuria, frequency, and dyspareunia. | ||||
| Keywords | ||||
| Trichomonas vaginalis; signs; symptoms; treatment; risky complications | ||||
|
Statistics Article View: 158 PDF Download: 337 |
||||
